Acute flaccid myelitis is a serious neurologic syndrome that affects mostly children and is characterized by the acute onset of limb weakness or paralysis. The report, published Aug. 4, includes an analysis of data from 238 patients with confirmed acute flaccid myelitis during 2018.
A majority of the patients (86 percent) experienced the onset of the condition between August and November. Most (92 percent) had prodromal fever, respiratory illness, or both, beginning a median of 6 days before experiencing limb weakness.
Overall, 98 percent of patients were hospitalized, 54 percent were admitted to an intensive care unit, and 23 percent required endotracheal intubation and mechanical ventilation.
Another peak acute flaccid myelitis year is anticipated this year, but it is unclear “whether or how the COVID-19 pandemic and recommended social-distancing measures will affect” trends, the report states.
As of July 31, there have been 16 confirmed cases of acute flaccid myelitis in 2020. There have been 633 confirmed cases since CDC began tracking the condition in August 2014.
More articles on public health:
Positive COVID-19 tests down in the South, West: 4 CDC updates
21 states where COVID-19 is spreading fastest, slowest: Aug. 4
Number of COVID-19 hospitalizations, state by state: Aug. 4
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
